451 related articles for article (PubMed ID: 9311705)
21. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of natural antibody synthesis by cyclophosphamide or 15-deoxyspergualin fails to prevent xenograft rejection in the guinea pig-to-rat model.
Leventhal JR; Platt JL; Flores HC; Gruber SA; Matas AJ; Bolman RM
Transplant Proc; 1992 Apr; 24(2):551. PubMed ID: 1566426
[No Abstract] [Full Text] [Related]
23. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model.
Leventhal JR; Flores HC; Gruber SA; Figueroa J; Platt JL; Manivel JC; Bach FH; Matas AJ; Bolman RM
Transplantation; 1992 Jul; 54(1):26-31. PubMed ID: 1631940
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
Chen D; Cao R; Guo H; Chen G; Wang X; Shen S; Chen S
Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288
[TBL] [Abstract][Full Text] [Related]
25. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats.
Lin Y; Vandeputte M; Waer M
Transplantation; 1998 Feb; 65(3):332-9. PubMed ID: 9484748
[TBL] [Abstract][Full Text] [Related]
26. Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation.
Valdivia LA; Monden M; Gotoh M; Nakano Y; Tono T; Mori T
Transplantation; 1990 Jul; 50(1):132-6. PubMed ID: 2368132
[TBL] [Abstract][Full Text] [Related]
27. FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation.
Sankary HN; Yin DP; Chong AS; Ma LL; Blinder L; Shen JK; Foster P; Williams JW
Transplantation; 1998 Oct; 66(7):832-7. PubMed ID: 9798690
[TBL] [Abstract][Full Text] [Related]
28. Negligible role for NK cells and macrophages in delayed xenograft rejection.
van Overdam KA; Verbakel CA; Kouwenhoven EA; van Rooijen N; de Bruin RW; IJzermans JN; Marquet RL
Transpl Int; 2000; 13 Suppl 1():S504-7. PubMed ID: 11112062
[TBL] [Abstract][Full Text] [Related]
29. Contribution of activated macrophages to the process of delayed xenograft rejection.
Lin Y; Vandeputte M; Waer M
Transplantation; 1997 Dec; 64(12):1677-83. PubMed ID: 9422401
[TBL] [Abstract][Full Text] [Related]
30. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy.
Kobayashi T; Taniguchi S; Neethling FA; Rose AG; Hancock WW; Ye Y; Niekrasz M; Kosanke S; Wright LJ; White DJ; Cooper DK
Transplantation; 1997 Nov; 64(9):1255-61. PubMed ID: 9371665
[TBL] [Abstract][Full Text] [Related]
31. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection.
Blakely ML; Van der Werf WJ; Berndt MC; Dalmasso AP; Bach FH; Hancock WW
Transplantation; 1994 Nov; 58(10):1059-66. PubMed ID: 7974711
[TBL] [Abstract][Full Text] [Related]
32. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
[TBL] [Abstract][Full Text] [Related]
33. Leflunomide controls rejection in hamster to rat cardiac xenografts.
Xiao F; Chong AS; Foster P; Sankary H; McChesney L; Koukoulis G; Yang J; Frieders D; Williams JW
Transplantation; 1994 Oct; 58(7):828-34. PubMed ID: 7940718
[TBL] [Abstract][Full Text] [Related]
34. The free radical scavenger S-PBN significantly prolongs DSG-mediated graft survival in experimental xenotransplantation.
Biglarnia AR; Emanuelsson C; Quach M; Clausen F; Larsson E; Schneider MK; Tufveson G; Lorant T
Xenotransplantation; 2012; 19(3):166-76. PubMed ID: 22702468
[TBL] [Abstract][Full Text] [Related]
35. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW
Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831
[TBL] [Abstract][Full Text] [Related]
36. Suppression of Delayed Xenograft Rejection by Resveratrol in a Hamster-to-Rat Cardiac Transplantation Model.
Lian Y; Gao C; Wu Y; Xia J; Leng Y; Liu Y; Zhu M; Chen J; Qi Z
Transplant Proc; 2017; 49(6):1483-1491. PubMed ID: 28736027
[TBL] [Abstract][Full Text] [Related]
37. Effects of a short course of leflunomide on T-independent B-lymphocyte xenoreactivity and on susceptibility of xenografts to acute or chronic rejection.
Yan Y; Verbeken E; Yu L; Rutgeerts O; Goebels J; Segers C; Lin Y; Waer M
Transplantation; 2005 Jan; 79(2):135-41; discussion 133-4. PubMed ID: 15665760
[TBL] [Abstract][Full Text] [Related]
38. Effect of graft preservation and IgM depletion on guinea pig to rat cardiac xenograft survival.
Hori S; Havaux X; Rubay R; Latinne D; Bazin H; Gianello P
Transplantation; 1997 Jun; 63(11):1554-61. PubMed ID: 9197345
[TBL] [Abstract][Full Text] [Related]
39. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
40. Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation.
Tanaka M; Murase N; Ye Q; Miyazaki W; Nomoto M; Miyazawa H; Manez R; Toyama Y; Demetris AJ; Todo S; Starzl TE
Transplantation; 1996 Sep; 62(5):681-8. PubMed ID: 8830837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
